Bayer AG
BAYRY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $28 | $25 | $22 | $19 |
| - Cash | $7 | $5 | $4 | $6 |
| + Debt | $47 | $45 | $39 | $41 |
| Enterprise Value | $67 | $66 | $57 | $53 |
| Revenue | $11 | $11 | $14 | $12 |
| % Growth | 5.1% | -21.8% | 17.1% | – |
| Gross Profit | $6 | $6 | $8 | $6 |
| % Margin | 55.4% | 59.4% | 59.1% | 51.2% |
| EBITDA | $1 | $0 | $4 | $2 |
| % Margin | 5.4% | 2.2% | 26.1% | 14.2% |
| Net Income | -$1 | -$0 | $1 | -$0 |
| % Margin | -10% | -1.9% | 9.5% | -2.9% |
| EPS Diluted | -0.29 | -0.05 | 0.33 | -0.085 |
| % Growth | -480% | -115.2% | 488.2% | – |
| Operating Cash Flow | $2 | $1 | -$1 | $5 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$1 |
| Free Cash Flow | $1 | $1 | -$1 | $4 |